天津医药 ›› 2026, Vol. 54 ›› Issue (11): 1194-1198.doi: 10.11958/20260636

• 临床研究 • 上一篇    下一篇

孕囊体积及瘢痕厚度联合血清β-HCG预测子宫瘢痕妊娠宫腔镜疗效的价值

王红(), 姚海波, 党春江△()   

  1. 唐山中心医院影像科 (邮编 063000)
  • 收稿日期:2026-03-06 修回日期:2026-05-08 出版日期:2026-11-15 发布日期:2026-11-10
  • 通讯作者: 党春江 E-mail:whzzyy2025@163.com;xiaodang1973@163.com
  • 作者简介:王红(1983),女,主管技师,主要从事影像技术方面研究。E-mail:whzzyy2025@163.com
  • 基金资助:
    河北省医学科学研究课题计划资助(20231841)

The value of gestational sac volume and scar thickness combined with serum β-HCG in predicting the therapeutic effect of hysteroscopy for uterine scar pregnancy

WANG Hong(), YAO Haibo, DANG Chunjiang△()   

  1. Department of Radiology, Tangshan Central Hospital, Tangshan 063000, China
  • Received:2026-03-06 Revised:2026-05-08 Published:2026-11-15 Online:2026-11-10
  • Contact: DANG Chunjiang E-mail:whzzyy2025@163.com;xiaodang1973@163.com

摘要:

目的 探讨基于MRI的孕囊体积、子宫瘢痕厚度联合血清β-人绒毛膜促性腺激素(HCG)水平对剖宫产术后子宫瘢痕妊娠(CSP)患者宫腔镜治疗疗效的预测价值。方法 回顾性纳入2021年7月—2025年3月唐山中心医院收治的297例CSP患者。根据治疗效果分为有效组和无效组。收集并比较2组患者的临床资料,采用多因素Logistic回归分析筛选CSP患者宫腔镜治疗无效的独立预测因素,并绘制受试者工作特征(ROC)曲线评估各因素及联合指标的预测效能。结果 297例患者中,36例(12.12%)治疗无效。无效组的孕囊体积、术前血清β-HCG水平高于有效组,而子宫瘢痕厚度低于有效组,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,孕囊体积增大(OR=1.705,95%CI:1.329~2.188)与β-HCG水平升高(OR=1.154,95%CI:1.088~1.224)是CSP患者宫腔镜治疗无效的独立危险因素,而瘢痕厚度增加(OR=0.265,95%CI:0.151~0.466)则是其保护因素(P<0.05)。ROC曲线分析显示,孕囊体积、瘢痕厚度和β-HCG单独预测治疗无效的曲线下面积(AUC)分别为0.691、0.771和0.770。将三者纳入Logistic回归模型构建联合预测因子,其AUC提升至0.900,预测效能显著优于任一单项指标(P<0.05)。结论 孕囊体积、瘢痕厚度及血清β-HCG水平是CSP患者宫腔镜治疗疗效的独立影响因素,三者联合构建的模型预测效能优异,可为术前识别高危患者、优化治疗策略提供参考依据。

关键词: 妊娠,异位, 宫腔镜检查, 磁共振成像, 绒毛膜促性腺激素,β亚单位,人, 子宫瘢痕妊娠

Abstract:

Objective To investigate the predictive value of magnetic resonance imaging (MRI)-based gestational sac volume, uterine scar thickness and serum β-human chorionic gonadotropin (β-HCG) levels for the therapeutic efficacy of hysteroscopic treatment in patients with cesarean scar pregnancy (CSP). Methods A total of 297 CSP patients admitted to Tangshan Central Hospital from July 2021 to March 2025 were retrospectively included. Based on treatment outcome, patients were divided into the effective group and the ineffective group. Clinical data were collected and compared between the two groups. Multivariate Logistic regression analysis was performed to identify independent predictors of hysteroscopic treatment failure. Receiver operating characteristic (ROC) curves were plotted to evaluate the predictive performance of individual factors and their combined indicators. Results Among 297 patients, 36 (12.12%) cases were ineffective to the treatment. The ineffective group had significantly larger gestational sac volume, higher preoperative serum β-HCG levels and thinner scar thickness compared to those of the effective group (P<0.05). Multivariate Logistic analysis revealed that increased gestational sac volume (OR=1.705, 95%CI: 1.329-2.188) and elevated β-HCG levels (OR=1.154, 95%CI: 1.088-1.224) were independent risk factors for hysteroscopic treatment failure, while greater scar thickness (OR=0.265, 95%CI: 0.151-0.466) was a protective factor (all P<0.05). ROC analysis demonstrated that the areas under the curve (AUC) for predicting treatment failure were 0.691 (gestational sac volume), 0.771 (scar thickness) and 0.770 (β-HCG) individually. The combined predictor incorporating all three factors achieved an AUC of 0.900, significantly outperforming any single indicator (P<0.05). Conclusion Gestational sac volume, scar thickness and serum β-HCG levels are independent factors influencing hysteroscopic treatment efficacy in CSP patients. Their combined use provides excellent predictive performance, offering valuable references for preoperative identification of high-risk patients and optimization of treatment strategies.

Key words: pregnancy, ectopic, hysteroscopy, magnetic resonance imaging, chorionic gonadotropin, beta subunit, human, cesarean scar pregnancy

中图分类号: